Kronos Bio's market cap is currently ―. The company's EPS TTM is $-1.995; its P/E ratio is -0.51; Kronos Bio is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 2.30M	$ 917.00K	$ 1.90M	$ 1.20M	-
Gross Profit	$ 2.30M	$ 900.00K	$ 1.90M	$ 1.20M	-
EBIT	$ -20.89M	$ -31.39M	$ -29.70M	$ -26.26M	$ -31.78M
EBITDA	$ -16.47M	$ -31.36M	$ -30.09M	$ -26.33M	$ -29.70M
Net Income Common Stockholders	$ -25.32M	$ -31.37M	$ -29.74M	$ -26.26M	$ -31.78M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 173.00M	$ 186.71M	$ 219.46M	$ 226.40M	$ 238.19M
Total Assets	$ 213.28M	$ 237.99M	$ 260.62M	$ 289.02M	$ 294.94M
Total Debt	$ 28.27M	$ 29.54M	$ 30.16M	$ 30.98M	$ 31.09M
Net Debt	$ -144.72M	$ -157.17M	$ -189.30M	$ -195.43M	$ -207.09M
Total Liabilities	$ 54.20M	$ 59.37M	$ 57.27M	$ 63.42M	$ 50.44M
Stockholders Equity	$ 159.08M	$ 178.62M	$ 203.34M	$ 225.60M	$ 244.50M
Cash Flow	-
Free Cash Flow	$ -25.05M	$ -22.80M	$ -25.33M	$ -6.04M	$ -26.00K
Operating Cash Flow	$ -25.02M	$ -22.59M	$ -25.02M	$ -5.92M	$ -26.00K
Investing Cash Flow	$ 31.56M	$ 35.79M	$ 5.37M	$ -6.36M	-
Financing Cash Flow	$ 191.00K	-	$ 376.00K	-	-

Currency in USD

Kronos Bio Earnings and Revenue History

Income Statement >

Kronos Bio Debt to Assets

Balance Sheet >

Kronos Bio Cash Flow

Cash Flow >

Kronos Bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing